India has approved the COVID-19 vaccine developed by AstraZeneca and Oxford University, paving the way for a huge immunization campaign in the world’s second most populous country.
Information and Broadcasting Minister Prakash Javadekar told reporters on Saturday the vaccine had been approved on Friday, confirming what sources close to the matter had told Reuters.
It is the first COVID-19 vaccine to be approved for emergency use by India, which has the highest number of infections after the US.
Javadekar said at least three more vaccines were waiting in line to be approved.
“India is perhaps the only country where at least four vaccines are getting ready,” he said.
“One was approved yesterday for emergency use, Serum’s COVISHIELD.” he said, referring to the fact that the shot is being made locally by the Serum Institute of India (SII).
India has reported more than 10 million COVID-19 cases, though its rate of infection has come down significantly from a mid-September peak.
The country hopes to inoculate 300 million of its 1.35 billion people in the first six to eight months of 2021.
Coronavirus: India tests vaccine delivery system with nationwide trialIndia tested its COVID-19 vaccine delivery system with a nationwide trial on Saturday as it prepares to roll out an inoculation program to stem the ... Coronavirus
Coronavirus: India COVID-19 cases pass 10 millionIndia surged past 10 million coronavirus cases on Saturday, official data showed, the second highest in the world although new infection rates have ... Coronavirus
Coronavirus: India has capacity to produce surplus of COVID-19 vaccines: MinisterIndia’s has enough capacity to produce COVID-19 vaccines for its needs and also export it to other countries that need its help, Finance Minister ... Coronavirus